Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer (EMERALD)
Interested in joining our team? We are looking for people that share our passion for and commitment to science.
We are a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics.
Through collaborations and partnerships and progressing our innovative pipeline, Radius has developed areas of expertise spanning from discovery and development to commercialization of its products. We seek to continue this growth with additional collaborative and partnering opportunities.
Attracting and developing high performing team members is a top priority at Radius. If you are seeking to become part of our outstanding team of professionals, we invite you to apply online today.